tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market
Holding RNXT?
Track your performance easily

RenovoRx (RNXT) Financial Statements

67 Followers

RenovoRx Financial Overview

RenovoRx's market cap is currently ―. The company's EPS TTM is $-0.572; its P/E ratio is -2.50; RenovoRx is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.47M$ -2.39M$ 2.51M$ -2.98M$ -2.33M
EBITDA$ -2.47M$ -2.39M$ 2.51M$ -2.98M$ -2.33M
Net Income Common Stockholders$ -2.47M$ -2.39M$ -1.08M$ -1.42M$ -2.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.60M$ 11.70M$ 4.40M$ 3.20M$ 6.00M
Total Assets$ 10.03M$ 12.00M$ 4.79M$ 3.52M$ 6.31M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -9.60M$ -11.70M$ -4.40M$ -3.20M$ -6.00M
Total Liabilities$ 2.96M$ 2.73M$ 3.02M$ 3.51M$ 5.13M
Stockholders Equity$ 7.07M$ 9.27M$ 1.77M$ 6.00K$ 1.19M
Cash Flow-
Free Cash Flow$ -2.19M$ -2.30M$ -2.20M$ -2.73M$ -2.77M
Operating Cash Flow$ -2.19M$ -2.30M$ -2.20M$ -2.73M$ -2.77M
Investing Cash Flow-----
Financing Cash Flow$ 15.00K$ 9.65M$ 5.42M-$ 5.00M
Currency in USD

RenovoRx Earnings and Revenue History

RenovoRx Debt to Assets

RenovoRx Cash Flow

RenovoRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis